The disease features demonstrated did not meet the World Health Organization (WHO) criteria for myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with SF3B1 mutation and thrombocytosis as the presence of at least 15% ring sideroblasts is regarded as an essential diagnostic criterion [1]. This evidence concerns the gene SF3B1 and thrombocytosis disease.